
What We're Reading: Drug Shortage Risk; FDA Approval Speed; and Zika's Ties to Birth Defects
Backup Drug Manufacturing Facilities Needed
There is a shift toward making more than one medication in a facility as companies seek to cut costs, more mergers take place, and manufacturing is outsourced. However, this consolidation is raising concerns about an increased risk of drug shortages,
FDA Strikes Back at Trump’s “Slow” Description
Days after President Donald Trump said in his address to the joint session of Congress that the FDA was “slow and burdensome,” former and current agency officials are speaking up.
Zika Virus Sharply Increases Likelihood of Babies Born With Birth Defects
Compared to before the Zika epidemic, women who contracted the virus during pregnancy are 20 times more likely to have babies with certain birth defects,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.